OOIR: Observatory of International Research

Papers

(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
For the Patient	83
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	74
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	43
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	34
Impact of steroids on the immune profiles of children with asthma living in the inner-city	29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	27
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	25
Venom allergen immunotherapy	24
Future directions in allergen immunotherapy	23
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	22
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	21
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	20
Operationalizing shared decision making in clinical practice	19
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	19
For the Patient	19
TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	18
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16
For the Patient	16
Evaluation and management of chronic cough in adults	15
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	15
For the Patient	14
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	14
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	13

The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	13
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	12
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	12
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	11
For the Patient	11
Treatment strategies for postviral olfactory dysfunction: A systematic review	11
For the Patient	11
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
Effects of mechanical washing and drying on the removal of pet allergens	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	10
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	10
Diagnostic utility of basophil CD203c expression in β-lactam allergy	10
Navigating the management complexity in long-term asymptomatic immunodeficiency	10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	9
For the patient	9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	9
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	9
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	9
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	9
Guidelines for management of hereditary angioedema: What is new? What is missing?	9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	9
Effect of COVID-19 on hereditary angioedema activity and quality of life	9
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	8
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist	8
Benralizumab in the management of rare primary eosinophilic lung diseases	8
Food-induced anaphylaxis in early childhood and factors associated with its severity	8
Evaluation of atopic diseases in patients with allergic contact dermatitis	8
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	8
Clinical features of anaphylaxis in children	8
Overview of secondary immunodeficiency	8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	7
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	7
For the Patient	7
Hematopoietic stem cell transplantation for primary immunodeficiency	7
Treatment options for chronic rhinosinusitis with nasal polyps	7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Curcumin does not significantly affect immediate skin tests	7
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	7
Paucigranulocytic asthma: Do sputum macrophages matter?	7

Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	7
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	7
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	7
The long COVID syndrome: A conundrum for the allergist/immunologist	7
The association of timothy grass allergy and cat ownership on cat sensitization	7
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	6
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Assessing cross-reactivity in allergen immunotherapy	6
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6